ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of 72-Hour Infusion of ON 01910.Na in Patients With MDS or AML

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00854945
Recruitment Status : Completed
First Posted : March 3, 2009
Last Update Posted : June 26, 2017
Sponsor:
Information provided by (Responsible Party):
Onconova Therapeutics, Inc.